NCT06845618View on ClinicalTrials.gov

Blood Tuberculosis DNA Levels to Monitor Tuberculosis Treatment

Not yet recruitingOBSERVATIONAL
Enrollment

140

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

September 30, 2027

Study Completion Date

September 30, 2027

Conditions
Mycobacterium TuberculosisTuberculosis, PulmonaryTuberculosis, Extra-Pulmonary
Trial Locations (1)

Unknown

Shoklo Malaria Research Unit (SMRU), Tak

All Listed Sponsors
lead

University of Oxford

OTHER

NCT06845618 - Blood Tuberculosis DNA Levels to Monitor Tuberculosis Treatment | Biotech Hunter | Biotech Hunter